Health Tech
ADVANCED THERAPIES - USA
The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.
The essentials
Event details
- Dates
- 4 November 2026 to 5 November 2026
- Organiser
- Terrapinn Holdings Ltd
- Tickets
- USD 445
- Expected attendance
- 1,200
- Industry
- Health Tech
Who attends
The audience
The event is designed for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.
As described by the organiser
Public discussion
What people are saying
Official hashtag #advancedtherapiesusa
- VideoInside Advanced Therapies Week 2026 | Where the Cell & Gene Therapy ...
Welcome to Advanced Therapies Week 2026, the global meeting point for cell and gene therapy innovation. From groundbreaking science to dealmaking by the beach, this is where the brightest minds
- VideoWomen in Advanced Therapies (WIAT) Summit 2025: The Power of ...
Women in Advanced Therapies (WIAT) Summit 2025: The Power of Investing in Women | ATW 2025 Investing in women isn't just right—it's essential for innovation and success. This session ...
- VideoAdvanced Therapies for Parkinson's 2025: Treatment Options and ...
In this webinar, Dr. Christina Swan discusses advanced therapies for Parkinson's disease when common first-line medications are no longer managing symptoms a...
Agenda themes
Topics covered
- Evidence, Pricing & Access
- Gene Modified Cell Therapy
- Cell Therapy
- Gene Therapy
On stage
Speakers
- Sulagna Bhattacharya, CEO, Nanoscope Therapeutics
- Daniel Cohen, Senior Director, Vector Engineering Genomics and Computational Biology, Roche Innovation Center
- Miguel Forte, Kiji Therapeutics
- Patrick Hanley, Chief and Director, Cellular Therapy Program, Children's National Medical Center
- Dennis Huang, Ultragenyx
- Manolis Kellis, Professor, Computer Science, MIT
- Dora Mitchell, Founder, Aleko Therapeutics, Inc
- Brock Reeve, CEO, Eos Bioinnovation
- Anne Brooks, SVP, Global Access, Operations and Proleukin Iovance Biotherapeutics, Iovance Biotherapeutics
- Maurits Geerlings, President & CEO, NanoCell Therapeutics
- Tom Leitch, CTO, KSQ Therapeutics, Inc
- Vanessa Almendro Navarro, Chief Commercialization Officer, City of Hope
- Cokey Nguyen, President and CEO, Atara Biotherapeutics
- Tay Salimullah, Venture Partner
- Gwendolyn Binder, President of Science and Technology, Cabaletta Bio
- Brian Campbell, VP & GM, US, Orchard Therapeutics
- Steven Feldman, Site Head and Scientific Director, Stanford GMP Facility, Stanford School of Medicine/Stanford HealthCar
- Tatyana Matveeva, Director of cGMP Operations, Mass General Hospital
- Johanna Rossell, Senior Vice President, General Manager, Regenerative Medicine, Sumitomo Pharma America Inc
On the floor
Sponsors and partners
- Cytiva
- Cellares Corporation
- terumo blood and cell technologies
- Entegris Inc
- Minaris Advanced Therapies
- World Courier, Inc
- Made Scientific
- ScaleReady
- BioMerieux Inc
- Catalent
- ACROBiosystems Inc
- Akron Bio
- Synthego
Logistics
Where to stay
Places to stay near the venue.
Omni Parker House
60 School Street, Boston, 02108
Hotel AKA Boston Common
90 Tremont Street, Boston, 02108
XV Beacon
15 Beacon Street, Boston, 02108
Hyatt Centric Faneuil
54-68 Devonshire Street, Boston, 02109
Churchill at Boston View
Club Quarters Hotel
161 Devonshire Street, Boston, 02110
The Bostonian Boston
The Godfrey Hotel Boston
505 Washington Street, Boston, 02111
Keep planning
Related events
Spot something wrong on this page? Report a correction and we will fix it.